Satellite Symposia

A number of programme slots have been set aside by the Scientific Programme Committee for industry sponsored satellite sessions.

All delegates are invited to attend the company satellite symposia. The programmes for these satellite symposia will be designed by the sponsoring companies and vetted by the Scientific Programme Committee to ensure balance, independence, objectivity and scientific rigour.


Saturday 14 May 2016, 17:00-18:30           Adalberto Liberia Room

Alexion Pharma GmbH

“Painting the future for patients with hypophosphatasia: Learning, diagnosing and treating.”

Chair: Dr. Maria Luisa Bianchi, IRCCS Istituto Auxologico Italiano, Milan

Welcome and Introduction to HPP

Dr Maria Luisa Bianchi, IRCCS Istituto Auxologico Italiano, Italy


Alkaline phosphatase: Building a replacement for a critical enzyme      

Prof. José Luis Millán, Sanford Children’s Health Research Center, Sanford-Burnham Medical Research Institute, USA


HPP or not HPP? Recognising the disease in infants and children            

Dr. Paul Arundel, Sheffield Children’s Hospital, UK


Learnings from adult patients and the patient registry 

Dr. Lothar Seefried, University of Würzburg, Germany



Sunday 15 May 2016, 12:30-14:00                              Main Auditorium

Merck Sharp & Dohme (MSD)

“Evolving Approaches for the Management of Osteoporosis: Signalling a Change in the Conversation”

Chair:    Nicola Napoli (Italy)

 Welcome and Opening Remarks

Nicola Napoli (Italy)

 “The Role of Cathepsin K in Bone Homeostasis”

Roland Baron (United States)


"High resolution Bone Imaging and what it tells us about Predicted Bone Strength"

Serge Ferrari (Switzerland)


“Clinical Benefits of Osteoporosis Therapy”

Michael McClung (United States)


Panel Discussion/ Q&A





Monday 16 May, 12:30 – 14:00                    Main Auditorium


“Evaluating the evidence – long-term treatment strategies in osteoporosis”

Chairs:    Bente Langdahl, Aarhus University Hospital, Aarhus, Denmark

               Serge Ferrari, Geneva University Hospital, Geneva, Switzerland


Comparing the short and long-term effects of osteoporosis treatments

Erik Fink Eriksen, Oslo University Hospital, Oslo, Norway


Transitioning between therapies: what have we learned?

Thierry Thomas, C.H.U Hôpital Bellevue, St Etienne, France


Understanding the impact of BMD in long-term osteoporosis treatment

Bente Langdahl, Aarhus University Hospital, Aarhus, Denmark